NasdaqCM - Delayed Quote USD

DarioHealth Corp. (DRIO)

1.4800 +0.0300 (+2.07%)
At close: April 26 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
20,352.0000
20,352.0000
27,656.0000
20,513.0000
7,576.0000
Cost of Revenue
14,368.0000
14,368.0000
18,001.0000
16,550.0000
5,063.0000
Gross Profit
5,984.0000
5,984.0000
9,655.0000
3,963.0000
2,513.0000
Operating Expense
62,173.0000
62,173.0000
66,465.0000
80,457.0000
32,416.0000
Operating Income
-56,189.0000
-56,189.0000
-56,810.0000
-76,494.0000
-29,903.0000
Net Non Operating Interest Income Expense
1,223.0000
1,223.0000
-2,177.0000
-40.0000
12.0000
Other Income Expense
-4,397.0000
-4,397.0000
-3,202.0000
-195.0000
446.0000
Pretax Income
-59,363.0000
-59,363.0000
-62,189.0000
-76,729.0000
-29,445.0000
Tax Provision
64.0000
64.0000
4.0000
32.0000
--
Net Income Common Stockholders
-63,511.0000
-63,511.0000
-63,836.0000
-76,761.0000
-33,103.0000
Diluted NI Available to Com Stockholders
-63,511.0000
-63,511.0000
-63,836.0000
-76,761.0000
-33,103.0000
Basic EPS
-1.93
-1.93
-2.54
-4.07
-4.01
Diluted EPS
-1.93
-1.93
-2.54
-4.07
-4.01
Basic Average Shares
28,371.9790
28,371.9790
23,635.0380
16,591.7180
5,963.3050
Diluted Average Shares
28,371.9790
28,371.9790
23,635.0380
16,591.7180
5,963.3050
Total Operating Income as Reported
-56,189.0000
-56,189.0000
-56,810.0000
-76,494.0000
-29,903.0000
Total Expenses
76,541.0000
76,541.0000
84,466.0000
97,007.0000
37,479.0000
Net Income from Continuing & Discontinued Operation
-59,427.0000
-59,427.0000
-62,193.0000
-76,761.0000
-29,445.0000
Normalized Income
-55,953.3700
-55,953.3700
-59,663.4200
-76,618.6500
-29,891.0000
Interest Income
1,868.0000
1,868.0000
506.0000
44.0000
61.0000
Interest Expense
--
--
1,876.0000
--
--
Net Interest Income
1,223.0000
1,223.0000
-2,177.0000
-40.0000
12.0000
EBIT
-59,363.0000
-59,363.0000
-60,313.0000
-76,729.0000
-29,903.0000
EBITDA
-54,378.0000
-54,378.0000
-55,596.0000
-72,272.0000
-29,713.0000
Reconciled Cost of Revenue
14,368.0000
14,368.0000
18,001.0000
16,550.0000
5,063.0000
Reconciled Depreciation
4,985.0000
4,985.0000
4,717.0000
4,457.0000
190.0000
Net Income from Continuing Operation Net Minority Interest
-59,427.0000
-59,427.0000
-62,193.0000
-76,761.0000
-29,445.0000
Total Unusual Items Excluding Goodwill
-4,397.0000
-4,397.0000
-3,202.0000
-195.0000
446.0000
Total Unusual Items
-4,397.0000
-4,397.0000
-3,202.0000
-195.0000
446.0000
Normalized EBITDA
-49,981.0000
-49,981.0000
-52,394.0000
-72,077.0000
-30,159.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
--
Tax Effect of Unusual Items
-923.3700
-923.3700
-672.4200
-52.6500
--
12/31/2020 - 3/14/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRPH ProPhase Labs, Inc.
4.7100
-4.85%
 
MDXH MDxHealth SA
2.4700
0.00%
 
ACRS Aclaris Therapeutics, Inc.
1.2000
+0.84%
 
NOTV Inotiv, Inc.
4.0500
-5.59%
 
CHEK Check-Cap Ltd.
2.2850
-0.65%
 
PMD Psychemedics Corporation
2.5500
-2.67%
 
NEO NeoGenomics, Inc.
14.14
+2.09%
 
BDSX Biodesix, Inc.
1.2350
-1.98%
 
AWH Aspira Women's Health Inc.
3.3266
+1.42%
 
TRIB Trinity Biotech plc
1.8300
0.00%